Study to Investigate Efficacy and Safety of a New Oral Contraceptive

Phase 3 Completed 1392 enrolled Bayer

RandomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the safety and effectiveness of a new 4-phasic preparation in the prevention of pregnancies in a large group of volunteers.

Timeline

Start: 2004-04
Primary completion: —
Completion: 2006-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DNG	Unknown	3 mg	—
Subject	EV	Unknown	2 mg	—

Indications

No indication recorded.